These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14361811)

  • 21. Experiences to date with the Salk vaccine.
    BAJDA L
    Miss Doct; 1955 Jul; 33(2):44-8. PubMed ID: 14393946
    [No Abstract]   [Full Text] [Related]  

  • 22. SALK VACCINE field tests.
    Northwest Med; 1954 Jun; 53(6):637-8. PubMed ID: 13176783
    [No Abstract]   [Full Text] [Related]  

  • 23. MSMS and the Salk vaccine experiment.
    J Mich State Med Soc; 1954 May; 53(5):537-8; passim. PubMed ID: 13212366
    [No Abstract]   [Full Text] [Related]  

  • 24. TECHNICAL report on poliomyelitis vaccine.
    Public Health Rep (1896); 1955 Aug; 70(8):738-47. PubMed ID: 13245927
    [No Abstract]   [Full Text] [Related]  

  • 25. [Production and control of poliomyelitis vaccine].
    LAHELLE O
    Tidsskr Nor Laegeforen; 1955 Dec; 75(24):847-9. PubMed ID: 13291347
    [No Abstract]   [Full Text] [Related]  

  • 26. [Report on the results of the testing of the Salk-vaccine].
    BESKE F
    Arztl Wochensch; 1955 May; 10(21):491-9. PubMed ID: 14387869
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliomyelitis vaccine.
    SHANHOLTZ MI
    Va Med Mon (1918); 1955 Sep; 82(9):413-4. PubMed ID: 13257008
    [No Abstract]   [Full Text] [Related]  

  • 28. POLIOMYELITIS vaccines.
    Lancet; 1955 Apr; 268(6869):851-2. PubMed ID: 14368888
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neurological complications of poliomyelitis vaccination].
    GRASER F; FORTONG G
    Monatsschr Kinderheilkd (1902); 1959 Apr; 107(4):227-30. PubMed ID: 13666707
    [No Abstract]   [Full Text] [Related]  

  • 30. Poliomyelitis vaccine status in May, 1956.
    HILLEBOE HE
    N Y State J Med; 1956 Jul; 56(14):2217-21. PubMed ID: 13334833
    [No Abstract]   [Full Text] [Related]  

  • 31. [Considerations on poliomyelitis vaccine].
    FRENNING H
    Sven Farm Tidskr; 1956 May; 60(13):360-2. PubMed ID: 13352227
    [No Abstract]   [Full Text] [Related]  

  • 32. Poliomyelitis vaccination--choosing a wise policy.
    Salk J
    Pediatr Infect Dis J; 1987 Oct; 6(10):889-93. PubMed ID: 3696820
    [No Abstract]   [Full Text] [Related]  

  • 33. NEW VACCINE may prove effective against paralysis.
    Cyprus Med J; 1952 Dec; 6(2):946-7. PubMed ID: 13231511
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress in epidemiology and control of poliomyelitis.
    JOHNSON DW
    Med J Aust; 1955 May; 42(1 19):669-71. PubMed ID: 14382877
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory aspects of the field trial of the poliomyelitis vaccine.
    BROWN GC
    Med Bull (Ann Arbor); 1955 Jun; 21(6):186-92. PubMed ID: 13247528
    [No Abstract]   [Full Text] [Related]  

  • 36. Poliomyelitis vaccines: killed or live?
    Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vaccination and poliomyelitis].
    MRAVUNAC B
    Lijec Vjesn; 1954; 76(5-6):234-8. PubMed ID: 13234684
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccination against poliomyelitis.
    VAN RIPER HE
    GP; 1954 Apr; 9(4):59-62. PubMed ID: 13142208
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccination against poliomyelitis.
    HENNINGSEN EJ; TULINIUS S
    Ugeskr Laeger; 1955 Apr; 117(15):462-5. PubMed ID: 14374111
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccination against poliomyelitis after Salk.
    GLANZMANN E
    Ther Umsch; 1955 May; 12(2):17-9. PubMed ID: 14396812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.